Skip to main content
. 2016 Nov 29;8(2):3226–3236. doi: 10.18632/oncotarget.13698

Figure 2. microRNA-25 protects human osteoblastic cells from Dex.

Figure 2

Stable osteoblastic OB-6 cells A-C. or hFOB1.19 cells D-F. expressing microRNA-25 (“miR-25”) or control microRNA (“miR-C”) were treated with or without Dex (1 μM) for 24 hours, cell viability (MTT assay, A and D), cell apoptosis (Histone DNA ELISA assay, B and E) and cell death (trypan blue assay, C and F) were tested. Experiments in this figure were repeated three times, and similar results were obtained. “Ctrl” stands for untreated control group. “Trans” stands for transfection reagents only. *p<0.05 vs. “miR-C” cells with Dex treatment.